Visceral obesity with and without metabolic syndrome: incidence and clinical impact in esophageal adenocarcinoma treated with curative intent

Author:

Elliott Jessie A1,Donlon Noel E1,Beddy Peter2,Donohoe Claire L1,Doyle Suzanne L13,King Sinead1,Ravi Narayanasamy1,Reynolds John V1

Affiliation:

1. Department of Surgery , Trinity Centre for Health Sciences, Trinity College Dublin, and St. James’s Hospital, Dublin 8, Ireland

2. Department of Radiology , St. James’s Hospital, Dublin 8, Ireland

3. School of Biological Sciences , Dublin Institute of Technology, Dublin 8, Ireland

Abstract

Abstract Visceral obesity (VO) and metabolic syndrome (MetS) are risk factors for esophageal adenocarcinoma (EAC); however, their impact on operative and oncological outcomes is unclear. The aim of this study was to determine the incidence of VO and MetS among patients with EAC, and to assess their independent impact on operative and oncological outcomes. A total of 454 consecutive patients undergoing treatment with curative intent were studied. Total, subcutaneous, visceral fat area (VFA), and lean body mass (LBM) were measured by computed tomography pretreatment, with VO defined as VFA >163.8cm2 for men and 80.1cm2 for women. MetS was defined per the ATPIII definition. Multivariable logistic and Cox proportional hazards regression were utilized to determine independent predictors of oncologic and operative outcomes. A total of 227 patients (50.0%) had VO. A total of 134 (30%) overall had MetS, 44% in the VO cohort. VO was associated with Barrett’s esophagus (P = 0.002) and lower cT (P = 0.006) and cN stage (P = 0.011), and improved disease-specific (P = 0.021) and overall survival (P = 0.012). No survival benefit existed for patients with VO who also had MetS. For operative complications, neither VO nor MetS increased the severity of complications, or mortality. However, VO was significantly (P = 0.035) associated with anastomotic leak and pneumonia (P = 0.037). MetS alone did not increase complication risk. VO increases specific major operative complications with no increase in mortality. VO improved survival, mainly relating to earlier stage disease; however, co-existent MetS abrogated this benefit. These seemingly paradoxical outcomes highlight manageable and potentially targetable perioperative challenges in the context of an overall favorable oncologic vista.

Funder

Health Research Board

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,General Medicine

Reference43 articles.

1. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies;Renehan;Lancet,2008

2. Global burden of 5 major types of gastrointestinal cancer [published online ahead of print, 2020 Apr 2];Arnold;Gastroenterology,2020

3. The epidemiology of esophageal adenocarcinoma;Coleman;Gastroenterology,2018

4. Adiposity and cancer at major anatomical sites: umbrella review of the literature;Kyrgiou;BMJ,2017

5. Body fatness and cancer--viewpoint of the IARC working group;Lauby-Secretan;N Engl J Med,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3